{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:54:47Z","timestamp":1794646487814,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI109135"],"award-info":[{"award-number":["R21AI109135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI123272"],"award-info":[{"award-number":["R56AI123272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI123272"],"award-info":[{"award-number":["R01AI123272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T02:46:31Z","timestamp":1497235591000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["APRIL:TACI axis is dispensable for the immune response to rabies vaccination"],"prefix":"10.1016","volume":"144","author":[{"given":"Shannon L.","family":"Haley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeni P.","family":"Tzvetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Lytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore R.","family":"Alugupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.06.004_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/mi.2009.106","article-title":"Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination","volume":"2","author":"Barone","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib2","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","article-title":"Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL","volume":"180","author":"Benson","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib3","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"Bossen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2017.06.004_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mi.2007.1","article-title":"HIV infection and the gastrointestinal immune system","volume":"1","author":"Brenchley","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib5","first-page":"553","volume":"27","author":"Cabasso","year":"1974"},{"key":"10.1016\/j.antiviral.2017.06.004_bib6","unstructured":"CDC - Doctors: Rabies Serology - Rabies [WWW Document], n.d. URL http:\/\/www.cdc.gov\/rabies\/specific_groups\/doctors\/serology.html."},{"key":"10.1016\/j.antiviral.2017.06.004_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus\u2013based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"Cenna","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.004_bib8","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"Cenna","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.06.004_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ni.1981","article-title":"Eosinophils are required for the maintenance of plasma cells in the bone marrow","volume":"12","author":"Chu","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.06.004_bib11","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.00995-13","article-title":"Reinvestigating the role of IgM in rabies virus postexposure vaccination","volume":"87","author":"Dorfmeier","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib12","doi-asserted-by":"crossref","first-page":"e2129","DOI":"10.1371\/journal.pntd.0002129","article-title":"Investigating the role for IL-21 in rabies virus vaccine-induced immunity","volume":"7","author":"Dorfmeier","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.06.004_bib13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/aid.2014.0319","article-title":"A\u00a0bivalent, chimeric rabies virus expressing simian immunodeficiency virus envelope induces multifunctional antibody responses","volume":"31","author":"Dunkel","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2017.06.004_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s100960050269","article-title":"Human rabies despite postexposure vaccination","volume":"18","author":"Gacouin","year":"1999","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.004_bib15","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02904-14","article-title":"DNA vaccine molecular adjuvants SP-d-BAFF and SP-d-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers","volume":"89","author":"Gupta","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02435-16","article-title":"Targeting vaccine-induced extrafollicular Pathway of B cell differentiation improves rabies post-exposure prophylaxis","author":"Haley","year":"2017","journal-title":"J.\u00a0Virol. JVI"},{"key":"10.1016\/j.antiviral.2017.06.004_bib17","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2017.06.004_bib18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2007.04.014","article-title":"Intestinal bacteria trigger T cell-independent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL","volume":"26","author":"He","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2017.06.004_bib19","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1074\/jbc.M411714200","article-title":"Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding","volume":"280","author":"Hymowitz","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.06.004_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2014.61","article-title":"IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors","volume":"28","author":"Jourdan","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.antiviral.2017.06.004_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2011.11.088","article-title":"Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine","volume":"30","author":"Kanagavelu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.06.004_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-12-387040-7.00007-X","article-title":"The role of toll-like receptors in the induction of immune responses during rabies virus infection","volume":"79","author":"Li","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2017.06.004_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/embo-reports\/kve198","article-title":"Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase","volume":"2","author":"L\u00f3pez-Fraga","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.antiviral.2017.06.004_bib24","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1128\/JVI.00800-13","article-title":"B\u00a0cell infection and activation by rabies virus-based vaccines","volume":"87","author":"Lytle","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"BAFF AND APRIL: a tutorial on B cell survival","volume":"21","author":"Mackay","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/erv.10.105","article-title":"Experimental rabies vaccines for humans","volume":"9","author":"McGettigan","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2017.06.004_bib27","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"McGettigan","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib28","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib29","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1128\/JVI.06259-11","article-title":"Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses","volume":"86","author":"Melchers","year":"2012","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.06.004_bib30","article-title":"Monoclonal antibodies for the prevention of rabies: theory and clinical practice","volume":"4","author":"Nagarajan","year":"2014","journal-title":"Antib. Technol. J."},{"key":"10.1016\/j.antiviral.2017.06.004_bib31","doi-asserted-by":"crossref","first-page":"e87098","DOI":"10.1371\/journal.pone.0087098","article-title":"ICAM-1-Based rabies virus vaccine shows increased infection and activation of primary murine B cells in\u00a0vitro and enhanced antibody titers in-vivo","volume":"9","author":"Norton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.06.004_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O'Connor","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2017.06.004_bib33","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.4049\/jimmunol.169.8.4314","article-title":"BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases","volume":"169","author":"Roschke","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.194.11.1691","article-title":"Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen","volume":"194","author":"Schneider","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2017.06.004_bib35","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.97.7.3544","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"Schnell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.06.004_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib37","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.1074\/jbc.M115.661405","article-title":"Stoichiometry of heteromeric BAFF and APRIL cytokines dictates their receptor binding and signaling properties","volume":"290","author":"Schuepbach-Mallepell","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.06.004_bib38","series-title":"Post-exposure Prophylaxis for Rabies","author":"Shayam","year":"2006"},{"key":"10.1016\/j.antiviral.2017.06.004_bib39","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI0215034","article-title":"APRIL modulates B and T cell immunity","volume":"109","author":"Stein","year":"2002","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2017.06.004_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(01)00130-3","article-title":"Regulation of the T-independent humoral response by TACI","volume":"14","author":"von B\u00fclow","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2017.06.004_bib41","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.05.008","article-title":"Rabies vaccines: WHO position paper\u2013recommendations","volume":"28","author":"WHO Publication","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.06.004_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/324628","article-title":"Postexposure treatment of rabies infection: can it be done without immunoglobulin?","volume":"34","author":"Wilde","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.004_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.192.1.137","article-title":"TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation","volume":"192","author":"Xia","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2017.06.004_bib44","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/eji.200838640","article-title":"APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response","volume":"38","author":"Xiao","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib45","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/MCB.21.12.4067-4074.2001","article-title":"B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses","volume":"21","author":"Xu","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/89790","article-title":"Activation and accumulation of B cells in TACI-deficient mice","volume":"2","author":"Yan","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/79802","article-title":"APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity","volume":"1","author":"Yu","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.004_bib48","first-page":"247426","article-title":"Effect of TACI signaling on humoral immunity and autoimmune diseases","volume":"2015","author":"Zhang","year":"2015","journal-title":"J.\u00a0Immunol. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421730222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421730222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T21:26:00Z","timestamp":1602278760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421730222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"alternative-id":["S016635421730222X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APRIL:TACI axis is dispensable for the immune response to rabies vaccination","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}